ALS (CP4) AI Stock Analysis

ALS

(Frankfurt:CP4)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Consistent Revenue GrowthMulti-year revenue growth indicates continued demand for ALS’s testing and analytical services across resource, environmental, pharmaceutical, and commercial markets. This expanding base supports operating scale, provides a foundation for investment, and strengthens the durability of future earnings.

Negative Factors

Earnings VolatilityThe sharp net-margin contraction followed by a substantial rebound shows that earnings have been uneven below the operating line. Such volatility reduces confidence in the predictability of reported profits and can make future returns more sensitive to non-operating costs or one-off effects.

ALS (CP4) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 7.87B
Dividend Yield: 1.98%
Average Volume (3M): 135
Price to Earnings (P/E): 33.9
Beta (1Y): 0.81
Revenue Growth: 3.97%
EPS Growth: 12.61%
Country: Germany
Employees: 23,342
Sector: Industrials
Sector Strength: 63
Industry: Consulting Services

ALS Business Overview & Revenue Model

Company Description

ALS Limited delivers expert technical services globally, specializing in analytical testing, precise measurement, and comprehensive inspection across various sectors. Its operations span continents, encompassing Africa, Asia-Pacific, Europe, the Midd...

ALS Peers Comparison

Overall Rating

UnderperformOutperform

Sector (63)

Financial Indicators

DE:CP4 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AU:MND	72Outperform	AUD 2.96B	23.48	22.77%	3.64%	29.43%	50.05%
AU:NWH	69Neutral	AUD 2.91B	19.25	23.03%	3.55%	31.39%	451.49%
AU:IMD	66Neutral	AUD 1.70B	22.19	11.89%	1.06%	20.56%	43.97%
AU:VNT	65Neutral	AUD 4.77B	17.68	48.18%	4.17%	-1.03%	8.70%
Sector *	63Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
AU:DOW	57Neutral	AUD 4.65B	22.17	11.01%	4.05%	-7.37%	59.81%

* Industrials Sector Average

Performance Comparison

DE:CP4 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:CP4	ALS Ltd.	12.70	0.84	7.07%
AU:DOW	Downer EDI Limited	7.21	-0.21	-2.76%
AU:IMD	Imdex Ltd	3.26	-0.07	-2.04%
AU:MND	Monadelphous Group Limited	29.67	7.89	36.20%
AU:NWH	NRW Holdings Limited	6.47	1.96	43.33%
AU:VNT	Ventia Services Group Limited	5.83	0.42	7.70%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

ALS AI Stock Analysis